Latest News: OncoMed Pharmaceuticals (NASDAQ:OMED), Keryx Biopharmaceuticals (NASDAQ:KERX), Brainstorm Cell Therapeutics (NASDAQ:BCLI)

Pacific Coast Oil Trust (NYSE:ROYT) shares moved down -5.63% in last trading session and ended the day at $1.34. ROYT has a return on assets of 8.10%. Pacific Coast Oil Trust (NYSE:ROYT) quarterly performance is -45.69%.

Pacific Coast Oil Trust (NYSE:ROYT) announced a cash distribution to the holders of its units of beneficial interest of $0.00593 per unit, payable on January 13, 2016, to unitholders of record on January 6, 2016. The Trust’s distribution relates to net profits and overriding royalties generated during November 2015 as provided in the conveyance of net profits and overriding royalty interest.

Apollo Education Group, Inc. (NASDAQ:APOL) ended the last trading day at $7.18. Company weekly volatility is calculated as 4.93% and price to cash ratio as 1.12. Apollo Education Group, Inc. (NASDAQ:APOL) showed a weekly performance of -10.30%.

Apollo Education Group, Inc. (NASDAQ:APOL) announced that it will report its fiscal 2016 first quarter results before market on Monday, January 11, 2016. The Company will host a conference call to discuss its results in more detail at 6:30 a.m. MT (8:30 a.m. ET) the same day.

OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) caters to the Healthcare space. Its weekly performance is -2.87%. On the last day of trading company shares ended up at $21.67. OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) distance from 50-day simple moving average (SMA50) is -25.69%.

OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) announced the appointment of Perry Karsen to the company’s Board of Directors. Mr. Karsen brings greater than 30 years of pharmaceutical and biotechnology industry experience to OncoMed’s Board. He recently retired from his role as Chief Executive Officer of Celgene Cellular Therapeutics and has held senior leadership positions within Celgene since 2004.

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) shares moved down -7.92% in last trading session and ended the day at $4.42. KERX Gross Margin is 37.60% and its has a return on assets of -78.40%. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) quarterly performance is 27.38%.

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) announced it will present at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 11, 2016 at 9:30 a.m. PST (12:30 p.m. PST).

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) caters to the Healthcare space. Its weekly performance is 4.53%. On the last day of trading company shares ended up at $3.00. Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) distance from 50-day simple moving average (SMA50) is -10.69%.

Maxim Group reissued their buy rating on shares of Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) in a research report published on Monday morning, MarketBeat reports. The firm currently has a $5.00 price objective on the biotechnology company’s stock, down from their prior price objective of $14.00.